Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal

Four nonvitamin K antagonist oral anticoagulants (NOACs) are approved for the prevention of stroke in patients with nonvalvular atrial fibrillation and for the treatment of venous thromboembolism. These includ...

Source: Critical Care - September 23, 2016 Category: Intensive Care Authors: Karen S. Brown, Hamim Zahir, Michael A. Grosso, Hans J. Lanz, Michele F. Mercuri and Jerrold H. Levy Source Type: research